Table 1 Overview of participants, their health status, the derived cultures and the outcome of the metagenomic profiling of the original fecal samplea
PARTICIPANTS | CULTIVATION | METAGENOMIC PROFILING | |||||||
---|---|---|---|---|---|---|---|---|---|
# | Disorder | breath CH4 [ppm] | Enrichment cultures (medium/syntroph) | Predominant archaeon | CH4 [%] | Bacteria [%] | Archaea [%] | M. smithii [% of archaea] | Cand. M. intestini [% of archaea] |
P15 | None | 30 | P15 (MpT1 / B. t.) | M. smithii | 16.5 | 99.76 | 0.24 | 88.8 | 5.1 |
P15 (MS / B. t.) | M. smithii | 20.7 | |||||||
P20 | None | 17 | P20 (MS / B. t.) | M. smithii | 22.2 | 99.82 | 0.18 | 76.5 | 3.5 |
P31 | None | 70 | P31 (MS / B. t.) | M. smithii | 23.6 | n.a. | |||
P32 | None | 44 | P32 (MS / B. t.) | M. smithii + DS | 23.4 | 99.87 | 0.13 | 90.8 | 6.3 |
P45 | None | 16 | P45 (MS / B. t.) | Cand. M. intestini | 23.8 | 99.84 | 0.16 | 7.9 | 79.5 |
P46 | None | 21 | P46 (MpT1 / B. t.) | Cand. M. intestini | 24.2 | 99.49 | 0.51 | 8.6 | 89.9 |
P51 | None | 28 | P51 (MS / B. t.) | Cand. M. intestini | 5.5 | 99.96 | 0.04 | 6.5 | 83.1 |
P82 | None | 22 | P82 (MpT1) | Cand. M. intestini | 25.2 | n.a. | |||
P34 | CD, flatulence, abdominal pain | 22 | n.a. | n.a. | n.a. | n.a. | |||
P48 | IBS | 26 | P48 (MpT1 / B. t.) | M. smithii | 22.2 | 99.66 | 0.34 | 94.0 | 5.3 |
P61 | IBS, Lactose I, SIBO | 21 | P61 (MpT1) | M. smithii | 23 | n.a. | |||
P66 | Lactose I | 55 | P66 (MS / B. t.) | M. smithii Cand. M. intestini | 21.8 | 99.16 | 0.84 | 94.6 | 4.8 |
P85 | CD | 6 | n.a. | n.a. | n.a. | 99.99 | 0.01 | 0 | 0 |
P86 | Lactose I | 13 | P86 (MS / B. t.) | Cand. M. intestini + DS | 22.4 | 99.99 | 0.01 | 63.9 | 3.8 |
P86 (MS) | M. smithii + DS | 21.1 | |||||||
P88 | IBS, lactose I, fructose I | 8 | P88 (MS) | M. smithii | 22.3 | 99.87 | 0.13 | 72.4 | 3.8 |
P89 | IBS, lactose I, pancreatic inflam. | 10 | P89 (MS / B. t.) | Cand. M. intestini | 21.2 | 99.78 | 0.22 | 5.6 | 88.6 |